28.03.2024

The "Europe 2024" event - organized by Die Zeit, Handelsblatt, Tagesspiegel and WirtschaftsWoche - took place in Berlin from 19.04.-20.04.2024. Prominent guests such as Chancellor Scholz and Economics Minister Habeck took part in the discussions on European policy in the face of the Ukraine invasion and the second main topic "Health - how can the EU position itself better for the future"

Prof. Hörauf (Director of IMMIP) and Dr. Gitzinger (Bioversys) were invited as discussion partners to the masterclass "Europe as a space for innovation: Together against antimicrobial resistance".  Moderated by Alexandra-Corinna Heeser, the discussion focused on the emergence of antimicrobial resistance (AMR), its impact on global healthcare and the problem of the lack of development of new antibiotics. Both participants made it clear that we will lose the fight against AMR, especially in Europe, if politicians do not improve the framework conditions for better remuneration of investments in new antibiotics and thus establish new pull mechanisms.

Link to the Pharmazeutische Zeitung report: https://www.pharmazeutische-zeitung.de/wie-koennen-mehr-antibiotika-entwickelt-werden-146361/